{"entity":{"type":"insider","cik":"0001650131","url":"/insider/0001650131","json_url":"/insider/0001650131.json","name":"Radovich Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":21,"first":"2016-01-07","last":"2026-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Radovich Peter","source":"filing","n_filings":21,"first_seen":"2016-01-07","last_seen":"2026-03-17"}],"transactions":[{"id":5885224,"accession":"0001650131-26-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001650131-26-000010","line_url":"/filing/0001650131-26-000010#line-3","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16515.0,"shares_display":"16,515","price_per_share":91.9779,"price_display":"91.98","price_state":"stated","total_value":1519015.0185,"total_display":"1,519,015.02","total_whole":"1,519,015","shares_owned_after":40272.0,"shares_owned_after_display":"40,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":6077887,"accession":"0001650131-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650131-26-000007","line_url":"/filing/0001650131-26-000007#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2631.0,"shares_display":"2,631","price_per_share":103.3035,"price_display":"103.30","price_state":"stated","total_value":271791.5085,"total_display":"271,791.51","total_whole":"271,792","shares_owned_after":20655.0,"shares_owned_after_display":"20,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":6060077,"accession":"0001650131-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001650131-26-000003","line_url":"/filing/0001650131-26-000003#line-2","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3143.0,"shares_display":"3,143","price_per_share":96.192,"price_display":"96.19","price_state":"stated","total_value":302331.456,"total_display":"302,331.46","total_whole":"302,331","shares_owned_after":23286.0,"shares_owned_after_display":"23,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-27","scope":"insider"},{"id":5934247,"accession":"0001650131-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001650131-26-000002","line_url":"/filing/0001650131-26-000002#line-2","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2382.0,"shares_display":"2,382","price_per_share":93.3252,"price_display":"93.33","price_state":"stated","total_value":222300.6264,"total_display":"222,300.63","total_whole":"222,301","shares_owned_after":20679.0,"shares_owned_after_display":"20,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":4466845,"accession":"0001415889-25-008557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008557","line_url":"/filing/0001415889-25-008557#line-2","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7879.0,"shares_display":"7,879","price_per_share":44.2143,"price_display":"44.21","price_state":"stated","total_value":348364.4697,"total_display":"348,364.47","total_whole":"348,364","shares_owned_after":18672.0,"shares_owned_after_display":"18,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":4466715,"accession":"0001415889-25-006955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-006955","line_url":"/filing/0001415889-25-006955","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14850.0,"shares_display":"14,850","price_per_share":45.5843958989899,"price_display":"45.58","price_state":"stated","total_value":676928.2791,"total_display":"676,928.28","total_whole":"676,928","shares_owned_after":13280.0,"shares_owned_after_display":"13,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider","n_lines":2},{"id":4244677,"accession":"0001415889-25-002982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002982","line_url":"/filing/0001415889-25-002982#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2627.0,"shares_display":"2,627","price_per_share":48.2226,"price_display":"48.22","price_state":"stated","total_value":126680.7702,"total_display":"126,680.77","total_whole":"126,681","shares_owned_after":26961.0,"shares_owned_after_display":"26,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4145616,"accession":"0001415889-25-002137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002137","line_url":"/filing/0001415889-25-002137#line-2","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3177.0,"shares_display":"3,177","price_per_share":47.9245,"price_display":"47.92","price_state":"stated","total_value":152256.1365,"total_display":"152,256.14","total_whole":"152,256","shares_owned_after":29588.0,"shares_owned_after_display":"29,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":4244451,"accession":"0001415889-25-001144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-001144","line_url":"/filing/0001415889-25-001144#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1998.0,"shares_display":"1,998","price_per_share":42.8153,"price_display":"42.82","price_state":"stated","total_value":85544.9694,"total_display":"85,544.97","total_whole":"85,545","shares_owned_after":27015.0,"shares_owned_after_display":"27,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":2222066,"accession":"0001415889-24-009046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009046","line_url":"/filing/0001415889-24-009046#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4303.0,"shares_display":"4,303","price_per_share":25.8,"price_display":"25.80","price_state":"stated","total_value":111017.4,"total_display":"111,017.40","total_whole":"111,017","shares_owned_after":29013.0,"shares_owned_after_display":"29,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-25","scope":"insider"},{"id":2995442,"accession":"0001415889-24-002755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-002755","line_url":"/filing/0001415889-24-002755#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1790.0,"shares_display":"1,790","price_per_share":26.1917,"price_display":"26.19","price_state":"stated","total_value":46883.143,"total_display":"46,883.14","total_whole":"46,883","shares_owned_after":34695.0,"shares_owned_after_display":"34,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":2273109,"accession":"0001415889-24-000884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000884","line_url":"/filing/0001415889-24-000884#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1408.0,"shares_display":"1,408","price_per_share":28.0345,"price_display":"28.03","price_state":"stated","total_value":39472.576,"total_display":"39,472.58","total_whole":"39,473","shares_owned_after":36485.0,"shares_owned_after_display":"36,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8439643,"accession":"0001209191-23-041344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041344","line_url":"/filing/0001209191-23-041344#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1425.0,"shares_display":"1,425","price_per_share":25.6466,"price_display":"25.65","price_state":"stated","total_value":36546.405,"total_display":"36,546.40","total_whole":"36,546","shares_owned_after":37675.0,"shares_owned_after_display":"37,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-05","scope":"insider"},{"id":3252402,"accession":"0001415889-24-008322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-008322","line_url":"/filing/0001415889-24-008322#line-1","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (PRESIDENT AND COO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT AND COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1379.0,"shares_display":"1,379","price_per_share":20.6223,"price_display":"20.62","price_state":"stated","total_value":28438.1517,"total_display":"28,438.15","total_whole":"28,438","shares_owned_after":33316.0,"shares_owned_after_display":"33,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2024-03-18","scope":"insider"},{"id":4793514,"accession":"0001209191-21-058605","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058605","line_url":"/filing/0001209191-21-058605#line-2","is_derivative":false,"issuer_cik":"0001650131","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001650131","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1364.0,"shares_display":"1,364","price_per_share":19.2555,"price_display":"19.26","price_state":"stated","total_value":26264.502,"total_display":"26,264.50","total_whole":"26,265","shares_owned_after":11273.0,"shares_owned_after_display":"11,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-01","scope":"insider"},{"id":6848830,"accession":"0000899243-18-002765","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-18-002765","line_url":"/filing/0000899243-18-002765#line-5","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":812.0,"shares_display":"812","price_per_share":57.3,"price_display":"57.30","price_state":"stated","total_value":46527.6,"total_display":"46,527.60","total_whole":"46,528","shares_owned_after":6817.0,"shares_owned_after_display":"6,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-02","scope":"insider"},{"id":6618665,"accession":"0000899243-18-002043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-002043","line_url":"/filing/0000899243-18-002043#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":3581.0,"shares_owned_after_display":"3,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-25","scope":"insider"},{"id":6343177,"accession":"0000899243-18-000952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-000952","line_url":"/filing/0000899243-18-000952#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":2684.0,"shares_owned_after_display":"2,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-10","filed_date":"2018-01-11","scope":"insider"},{"id":4104538,"accession":"0000899243-17-025039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-025039","line_url":"/filing/0000899243-17-025039#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer (Senior VP, Operations)","role_mark":"O","role_mark_label":"Officer (Senior VP, Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":437500.0,"total_display":"437,500.00","total_whole":"437,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-10-31","scope":"insider"},{"id":4180595,"accession":"0000899243-17-021480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-021480","line_url":"/filing/0000899243-17-021480#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2410.0,"shares_display":"2,410","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":72300.0,"total_display":"72,300.00","total_whole":"72,300","shares_owned_after":2684.0,"shares_owned_after_display":"2,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-31","filed_date":"2017-09-05","scope":"insider"},{"id":2304889,"accession":"0000899243-16-011350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-011350","line_url":"/filing/0000899243-16-011350#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001650131","owner_name":"Radovich Peter","owner_display_name":"Radovich Peter","owner_url":"/insider/0001650131","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2016-01-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Officer (PRESIDENT AND COO)","n_filings":15,"first_seen":"2021-10-01","last_seen":"2026-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Officer","n_filings":6,"first_seen":"2016-01-07","last_seen":"2018-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001650131","retrieved_at":"2026-08-24T05:33:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}